Actively Recruiting
Drug-drug Interactions With Anti-tuberculous Drugs
Led by Cairo University · Updated on 2024-08-22
400
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to assess the prevalence and the outcome of prescribing drugs known to have major drug-drug interactions with anti-tuberculous drugs among Kasr Alainy tuberculous patients.
CONDITIONS
Official Title
Drug-drug Interactions With Anti-tuberculous Drugs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with tuberculosis and referred to the Tuberculosis outpatient clinic at Kasr Alainy Faculty of Medicine, Cairo University after ethical approval
You will not qualify if you...
- Refusal by the patient or patient's guardian to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Omnia Azmy Nabeh
Cairo, Egypt, 11562
Actively Recruiting
Research Team
O
Omnia Azmy Nabeh, MD
CONTACT
H
Hoda Mohamed Abdel-Hamid
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here